Literature DB >> 3368777

Surface morphology of human airway mucosa: normal, carcinoma or cystic fibrosis.

P K Jeffery1, A P Brain.   

Abstract

The study presents preliminary qualitative findings of an investigation of grossly normal main and lobar bronchi at sites distant to well circumscribed tumour (n = 15), adjacent to tumour (n = 5) or of airways obtained during heart/lung transplantation in patients with cystic fibrosis (CF, n = 3). In the normal airways the surface epithelium was on average 50 micron thick, pseudo-stratified and rested on a roughly contoured basement membrane. A variety of cell types were identified although many were obscured by a dense covering of cilia, occasionally interrupted by foci of squamous metaplasia. Submucosal gland structure was observed in chance vertical fractures of the airway wall. Tissue adjacent to tumour showed sloughing, squamous metaplasia, pleomorphism and cell surface projections of stubby microvilli or tortuous microridges. The surface morphology of the three CF patients showed no feature unique to the condition, albeit secretions were found adherent to surface lining associated with isolated bacteria and groups of free cells (probably lymphocytes). In each of the three cases the epithelial surface was densely ciliated, interspersed with mucous (i.e., goblet) cells. Submucosal gland collecting ducts had dilated lumena.

Entities:  

Mesh:

Year:  1988        PMID: 3368777

Source DB:  PubMed          Journal:  Scanning Microsc        ISSN: 0891-7035


  15 in total

Review 1.  Recognition of mucin components by Pseudomonas aeruginosa.

Authors:  R Ramphal; S K Arora
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

Review 2.  The role of bacterial adhesion in cystic fibrosis including the staphylococcal aspect.

Authors:  R Ramphal
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

Review 3.  Microbiology of cystic fibrosis lung infections: themes and issues.

Authors:  J R Govan; J W Nelson
Journal:  J R Soc Med       Date:  1993       Impact factor: 5.344

4.  Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients.

Authors:  Dieter Worlitzsch; Robert Tarran; Martina Ulrich; Ute Schwab; Aynur Cekici; Keith C Meyer; Peter Birrer; Gabriel Bellon; Jürgen Berger; Tilo Weiss; Konrad Botzenhart; James R Yankaskas; Scott Randell; Richard C Boucher; Gerd Döring
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

5.  Mucinophilic and chemotactic properties of Pseudomonas aeruginosa in relation to pulmonary colonization in cystic fibrosis.

Authors:  J W Nelson; M W Tredgett; J K Sheehan; D J Thornton; D Notman; J R Govan
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

6.  Polarization of protease-activated receptor 2 (PAR-2) signaling is altered during airway epithelial remodeling and deciliation.

Authors:  Ryan M Carey; Jenna R Freund; Benjamin M Hariri; Nithin D Adappa; James N Palmer; Robert J Lee
Journal:  J Biol Chem       Date:  2020-04-02       Impact factor: 5.157

7.  Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa.

Authors:  Milan Bajmoczi; Mihaela Gadjeva; Seth L Alper; Gerald B Pier; David E Golan
Journal:  Am J Physiol Cell Physiol       Date:  2009-04-22       Impact factor: 4.249

8.  A murine model of chronic mucosal colonization by Pseudomonas aeruginosa.

Authors:  G B Pier; G Meluleni; E Neuger
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

Review 9.  Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity.

Authors:  Gerald B Pier
Journal:  Int J Med Microbiol       Date:  2007-04-27       Impact factor: 3.473

10.  Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.

Authors:  G B Pier; M Grout; T S Zaidi; J C Olsen; L G Johnson; J R Yankaskas; J B Goldberg
Journal:  Science       Date:  1996-01-05       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.